A novel risk calculator developed by researchers at the Cleveland Clinic encourages patients with both type 2 diabetes and obesity to weigh their treatment options for optimal long-term health.

A study published in Hypertension this month has found that exercise—historically one of our best first-line defenses against cardiovascular disease—could also negatively impact heart health in certain situations, including at work.

A cross-sectional study of heart patients undergoing ICD implantation revealed a marked decline in the use of defibrillation testing over time in the U.S., suggesting the precaution might be losing its value as a clinical tool.

Two studies reach conflicting conclusions while underscoring the need for best practice guidelines to fill the current vacuum.

The latest numbers on cardiovascular deaths put the focus on innovative ways to point the trend line down again.

Research out of Brigham and Women’s Hospital in Boston found heart failure patients who self-identify as black, Latinx or female are less likely to be admitted to the hospital’s cardiology department, suggesting admission bias might be a partial contributor to known racial disparities in HF outcomes.

The combo drug sacubitril/valsartan was associated with early improvements in health status in a study of nearly 4,000 patients with HFrEF.

Most patients on DOACs supplement their regimen with over-the-counter products, and one-third take at least one additional product that directly interferes with their blood thinners, according to work published in the Journal of the American Geriatrics Society.